Cyber Monday Deal: Up to 60% off InvestingProCLAIM SALE

As rebel-held Syria fears virus, just one machine is there to test

Published 2020-04-14, 07:33 a/m
© Reuters. Mohamad Shahim Makki, a doctor, wears protective gear as he works at a laboratory that deals with coronavirus disease (COVID-19) testing in Idlib

By Khalil Ashawi

IDLIB, Syria (Reuters) - A single machine at Mohamad Shahim Makki's medical centre in Idlib province, part of Syria's last rebel stronghold, is the only alarm that will sound when the coronavirus strikes a population of millions of the world's most vulnerable people.

Makki's Epidemiological Surveillance Laboratory has the only device in areas outside of Syrian government control equipped to run a polymerase chain reaction (PCR) test to detect the virus.

As of a few days ago, just 120 tests had been carried out on just 300 samples.

While all have been negative so far, doctors and relief agencies fear that crowded camps for displaced people, and medical facilities ravaged by years of war, would make any contagion rapid and lethal.

Samples have begun to come into the lab faster, with 5,000 received in the last two days, though it is not yet clear how many of them can be processed or how quickly.

The machine "is not sufficient to serve all these people, so there is pressure on the device. And since it is the only one, strict criteria are being used to select samples," said Makki.

Northwest Syria is the last part of the country still held by fighters trying to overthrow president Bashar al-Assad. It is home to more than 3 million people, most of whom fled other parts of Syria in a civil war that began nine years ago.

"If corona spreads in the northwest it will be a catastrophe. The number of deaths will be very big and infections will be huge, in the hundreds of thousands," Ahmad al-Dbis of the U.S.-based medical charity UOSSM, which operates in opposition territory, told Reuters last month.

Plans to equip other centres with PCR test devices have been slowed by their high cost and the training needed to run them.

"In the liberated areas we have major weaknesses in the health sector because of the war and because of the systematic targeting of hospitals and health centres," said Makki.

The government, backed by Russia and Iran, launched a push earlier this year to capture Idlib, sending hundreds of thousands of residents fleeing, many of them people who were already displaced.

In recent days thousands of Syrians have begun to leave camps near the Turkish border, some wary of the virus reaching tightly packed quarters, choosing instead to return to Idlib after a ceasefire struck last month that has restored calm.

© Reuters. Mohamad Shahim Makki, a doctor, wears protective gear as he works at a laboratory that deals with coronavirus disease (COVID-19) testing in Idlib

In the rest of Syria, Damascus has reported 25 coronavirus cases and two deaths in government-held areas. It has shut businesses, halted flights, and imposed a curfew to curb the spread of the virus.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.